E. Onsøyen

1.3k total citations
17 papers, 935 citations indexed

About

E. Onsøyen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmaceutical Science. According to data from OpenAlex, E. Onsøyen has authored 17 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Pharmaceutical Science. Recurrent topics in E. Onsøyen's work include Bacterial biofilms and quorum sensing (5 papers), Cystic Fibrosis Research Advances (4 papers) and Antimicrobial Peptides and Activities (3 papers). E. Onsøyen is often cited by papers focused on Bacterial biofilms and quorum sensing (5 papers), Cystic Fibrosis Research Advances (4 papers) and Antimicrobial Peptides and Activities (3 papers). E. Onsøyen collaborates with scholars based in United Kingdom, Norway and Denmark. E. Onsøyen's co-authors include Katja E. Hill, David W. Thomas, Rolf Myrvold, Peter W. Dettmar, Iain A. Brownlee, Jeffrey P. Pearson, M. E. Havler, Adrian Allen, Philip D. Rye and Charlotte Emanuel and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Antimicrobial Agents and Chemotherapy.

In The Last Decade

E. Onsøyen

17 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Onsøyen United Kingdom 13 301 273 175 147 126 17 935
Matthew D. Wilcox United Kingdom 20 411 1.4× 142 0.5× 265 1.5× 127 0.9× 47 0.4× 37 1.4k
Yulong Tan China 22 557 1.9× 108 0.4× 213 1.2× 57 0.4× 68 0.5× 51 1.2k
Rolf Myrvold Norway 8 153 0.5× 80 0.3× 81 0.5× 87 0.6× 67 0.5× 10 455
Ahmet Levent Baş Türkiye 13 99 0.3× 107 0.4× 63 0.4× 20 0.1× 78 0.6× 41 689
Т. С. Запорожец Russia 21 295 1.0× 816 3.0× 137 0.8× 15 0.1× 35 0.3× 74 1.4k
Ahya Abdi Ali Iran 18 475 1.6× 33 0.1× 119 0.7× 46 0.3× 221 1.8× 49 1.0k
Fatih Hatıpoğlu Türkiye 11 49 0.2× 108 0.4× 88 0.5× 19 0.1× 57 0.5× 35 638
Khaled Y. Farroh Egypt 20 123 0.4× 106 0.4× 71 0.4× 13 0.1× 47 0.4× 58 1.1k
Vesselin Kussovski Bulgaria 19 183 0.6× 65 0.2× 149 0.9× 499 3.4× 44 0.3× 69 1.3k
Chang‐Ro Lee South Korea 24 755 2.5× 160 0.6× 157 0.9× 20 0.1× 302 2.4× 58 1.7k

Countries citing papers authored by E. Onsøyen

Since Specialization
Citations

This map shows the geographic impact of E. Onsøyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Onsøyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Onsøyen more than expected).

Fields of papers citing papers by E. Onsøyen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Onsøyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Onsøyen. The network helps show where E. Onsøyen may publish in the future.

Co-authorship network of co-authors of E. Onsøyen

This figure shows the co-authorship network connecting the top 25 collaborators of E. Onsøyen. A scholar is included among the top collaborators of E. Onsøyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Onsøyen. E. Onsøyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ermund, Anna, Christian V. Recktenwald, Gudmund Skjåk‐Bræk, et al.. (2017). OligoG CF‐5/20 normalizes cystic fibrosis mucus by chelating calcium. Clinical and Experimental Pharmacology and Physiology. 44(6). 639–647. 26 indexed citations
2.
Rye, Philip D., et al.. (2016). A novel guluronate oligomer improves intestinal transit and survival in cystic fibrosis mice. Journal of Cystic Fibrosis. 15(6). 745–751. 19 indexed citations
3.
Wang, Hengzhuang, Zhijun Song, Oana Ciofu, et al.. (2016). OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model. Antimicrobial Agents and Chemotherapy. 60(5). 2620–2626. 58 indexed citations
4.
Pritchard, M., Lydia C. Powell, Georgina Menzies, et al.. (2016). A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease. Molecular Pharmaceutics. 13(3). 863–872. 64 indexed citations
5.
Weiser, Rebecca, Julian R. Marchesi, Philip D. Rye, et al.. (2016). 35 Standardised cultivation-independent methods to understand the effect of OligoG on Burkholderia and microbial diversity in the CF lung during a clinical trial. Journal of Cystic Fibrosis. 15. S60–S60. 3 indexed citations
6.
Pritchard, M., Elaine L. Ferguson, Lydia C. Powell, et al.. (2015). 139 OligoG fluorescent conjugation for localisation in a mucoid pseudomonal biofilm. Journal of Cystic Fibrosis. 14. S93–S93. 1 indexed citations
7.
Tøndervik, Anne, Håvard Sletta, Geir Klinkenberg, et al.. (2014). Alginate Oligosaccharides Inhibit Fungal Cell Growth and Potentiate the Activity of Antifungals against Candida and Aspergillus spp. PLoS ONE. 9(11). e112518–e112518. 73 indexed citations
8.
Powell, Lydia C., Saira Khan, Chris J. Wright, et al.. (2013). The effect of alginate oligosaccharides on the mechanical properties of Gram-negative biofilms. Biofouling. 29(4). 413–421. 68 indexed citations
9.
Roberts, Jessica, Charlotte Emanuel, Lydia C. Powell, et al.. (2013). An in vitro study of alginate oligomer therapies on oral biofilms. Journal of Dentistry. 41(10). 892–899. 31 indexed citations
10.
Powell, Lydia C., M. Pritchard, Charlotte Emanuel, et al.. (2013). A Nanoscale Characterization of the Interaction of a Novel Alginate Oligomer with the Cell Surface and Motility of Pseudomonas aeruginosa. American Journal of Respiratory Cell and Molecular Biology. 50(3). 483–492. 58 indexed citations
11.
Wang, Hengzhuang, Zhen Song, Oana Ciofu, et al.. (2013). WS17.1 Biofilm disruption and potentiating antimicrobial effects of a novel alginate oligomer on Pseudomonas aeruginosa in a murine lung infection model. Journal of Cystic Fibrosis. 12. S34–S34. 1 indexed citations
12.
Khan, Saira, Anne Tøndervik, Håvard Sletta, et al.. (2012). Overcoming Drug Resistance with Alginate Oligosaccharides Able To Potentiate the Action of Selected Antibiotics. Antimicrobial Agents and Chemotherapy. 56(10). 5134–5141. 131 indexed citations
13.
Anderson, Robert, Juliet Brodie, E. Onsøyen, & Alan T. Critchley. (2007). Eighteenth International Seaweed Symposium. 23 indexed citations
14.
Brownlee, Iain A., Adrian Allen, Jeffrey P. Pearson, et al.. (2005). Alginate as a Source of Dietary Fiber. Critical Reviews in Food Science and Nutrition. 45(6). 497–510. 256 indexed citations
15.
Snaar, J.E.M., Richard Bowtell, Frank Hampson, et al.. (2004). Localised mapping of water movement and hydration inside a developing bioadhesive bond. Journal of Controlled Release. 95(3). 435–446. 12 indexed citations
16.
Onsøyen, E., et al.. (2003). Sustained release of water-soluble drug from directly compressed alginate tablets. European Journal of Pharmaceutical Sciences. 20(4-5). 403–407. 48 indexed citations
17.
Draget, Kurt I., et al.. (1998). Na- and K-alginate; effect on Ca2+-gelation. Carbohydrate Polymers. 35(1-2). 1–6. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew D. Wilcox Breakdown of academic impact, for papers by Yulong Tan Breakdown of academic impact, for papers by Rolf Myrvold Breakdown of academic impact, for papers by Ahmet Levent Baş Breakdown of academic impact, for papers by Т. С. Запорожец Breakdown of academic impact, for papers by Ahya Abdi Ali Breakdown of academic impact, for papers by Fatih Hatıpoğlu Breakdown of academic impact, for papers by Khaled Y. Farroh Breakdown of academic impact, for papers by Vesselin Kussovski Breakdown of academic impact, for papers by Chang‐Ro Lee
Rankless by CCL
2026